About: Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)
Creator	Gupta, Ritesh Misra, Anoop
Source	Elsevier; Medline; PMC
abstract	Abstract Background and aims Multiple issues in management of COVID have emerged, but confusion persists regarding rational interpretation. Aim of this brief review is to review these issues based on current literature. Methods This is a narrative review with Pubmed and Google Scholar search till 23 March 2020. Search terms were, COVID-19, treatment of coronavirus, COVID 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ACE-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease. Results We discuss evidence regarding role of chloroquine and hydroxychloroquine in treatment and prophylaxis, use of inhibitors of the renin angiotensin system, safety of ibuprofen, unusual clinical features like gastrointestinal symptoms and interpretation of tests for cardiac enzymes and biomarkers. Conclusions While our conclusions on management of COVID-19 patients with co-morbidities are based on current evidence, however, data is limited and there is immediate need for fast track research.
has issue date	2020-06-30(xsd:dateTime)
bibo:doi	10.1016/j.dsx.2020.03.012
bibo:pmid	32247213
has license	els-covid
sha1sum (hex)	929545880647bc518d1b5ab4112d452dcf9b36d9
schema:url	https://doi.org/10.1016/j.dsx.2020.03.012
resource representing a document's title	Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)
has PubMed Central identifier	PMC7102586
has PubMed identifier	32247213
schema:publication	Diabetes & Metabolic Syndrome: Clinical Research & Reviews
resource representing a document's body	covid:929545880647bc518d1b5ab4112d452dcf9b36d9#body_text
is schema:about of	named entity 'diarrhoea' named entity 'COVID-19' named entity 'terms' named entity 'GASTROINTESTINAL SYMPTOMS' named entity 'RESEARCH' named entity 'DISCUSS' named entity 'HYDROXYCHLOROQUINE' named entity 'PUBMED' named entity 'SCHOLAR' named entity 'COVID' named entity 'chloroquine' named entity 'ibuprofen' named entity 'Methods' named entity 'Pubmed' named entity 'tests' named entity 'COVID-19' named entity 'angiotensin' named entity 'ibuprofen' named entity 'Aim' named entity 'chloroquine' named entity 'co-morbidities' named entity 'gastrointestinal symptoms' named entity 'ACE-inhibitors' named entity 'biomarkers' named entity 'current literature' named entity 'Orchitis' named entity 'receptor' named entity 'cardiovascular disease' named entity 'NSAIDs' named entity 'renal function' named entity 'hypokalaemia' named entity 'lysosomes' named entity 'natriuretic peptides' named entity 'health problems' named entity 'virus' named entity 'pneumonia' named entity 'WHO' named entity 'renal transplant' named entity 'ibuprofen' named entity 'EC50' named entity 'hydroxychloroquine' named entity 'ICMR' named entity 'hypertension' named entity 'host cell' named entity 'Mouse Hepatitis virus' named entity 'infection' named entity 'PubMed' named entity 'COVID' named entity 'SARS' named entity 'virus' named entity 'virus' named entity 'HCQ' named entity 'anti-viral' named entity 'binding site' named entity 'RAS pathway' named entity 'fever' named entity 'chikungunya' named entity 'kidney' named entity 'Vesicular Stomatitis virus' named entity 'Hypokalaemia' named entity 'COVID' named entity 'renal function' named entity 'chloroquine' named entity 'ACE-2' named entity 'adverse effects' named entity 'chloroquine' named entity 'COVID' named entity 'clinical presentation' named entity 'SARS' named entity 'antiinflammatory' named entity 'virion' named entity 'HCQ' named entity 'acute kidney injury' named entity 'proinflammatory cytokines' named entity 'cardiovascular disease' named entity 'alveolar epithelial cells' named entity 'infection' named entity 'receptor expression' named entity 'viral replication' named entity 'vomiting'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software